Language produced under the influence of the psychedelic drug lysergic acid diethylamide displays increased levels of entropy and reduced semantic coherence, according to new research published in the journal Consciousness and Cognition.
Exploring the companies and themes that make up this emerging and exciting new sector
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta
Levitee Labs announces definitive agreements to acquire 3 specialized pharmacies, a "leading telehealth provider", and 5 addiction clinics.
The Psychedelics Revolution: Abundant Opportunities For More Public Companies
The psychedelic drug industry represents the best investment opportunity in life sciences of this century. A multitude of opportunities.
Small Pharma Establishes Psychedelic-assisted Therapy Training Program
Small Pharma is starting its DMT-based training program for psychedelic-assisted therapy with its Phase IIa clinical trial due to start immediately.
The Other Magic Mushroom: Why a Canadian Startup Is Suddenly Interested in the Fungus From Super Mario
Psyched Wellness wants to bring the Amanita muscaria fungus to the masses.
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
Novamind seeks to increase access for U.S. investors through its OTC application.
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Mydecine files a new patent application in support of its MDMA-based psychedelic drug research.
The Mental Health Crisis Now Dwarfs Covid-19
The Mental Health Crisis is not only a much larger pandemic than the Covid-19 pandemic. It is also much deadlier.
Psilocybin induces rapid and persistent growth of neural connections in the brain’s frontal cortex, study finds
Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Field Trip Health Ltd., a leader in the development and delivery of psychedelic therapies, reported its fiscal first quarter 2022 results for the three months ended June 30, 2021.
California Activists File Psilocybin Legalization Ballot Measure As Legislature Advances Broader Psychedelics Bill
California psychoactive compound activists are embarking on a bold journey, filing a petition for the 2022 ballot to make the state the first in the nation to legalize psilocybin mushrooms for any use.